did serena williams use glp-1 EXCLUSIVE: has been taking a medication to help with her recent weight loss, she revealed for the first time in an exclusive TODAY interview., The 23-time Grand Slam champion Serena Williams discusses GLP-1 use

The STEP (Semaglutide Treatment Effect in People with obesity) 1 trial was a randomized, placebo-controlled trial that evaluated the efficacy of once-weekly subcutaneous (SC) semaglutide 2.4 mg plus lifestyle interventions in adults with obesity without diabetes (n = 1961)

Depending on the ingredients within the patch, they may cause a variety of side effects such as headaches or an increase in heart rate

Similarly, mixing Vyvanse with SSRIs or other serotonergic drugs increases the risk of serotonin syndrome, a potentially fatal condition characterized by confusion, rapid heart rate, and seizures

GLP-1s fit better with long-term plans, while Phentermine is for quick bursts of support